|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,507 INR | -0.89% |
|
-1.07% | +19.62% |
Sun Pharmaceutical Industries Limited (NSEI:SUNPHARMA) entered into agreement to acquire 27.39% stake in Remidio Innovative Solutions Pvt. Ltd. for INR 1.5 billion on February 18, 2023. The consideration to be paid in cash.
The revenue from operations for the year 2021-22 on consolidated basis was INR 266.07 million. The transaction is expected to complete by the end of February, 2023
| 1st Jan change | Capi. | |
|---|---|---|
| +19.62% | 43.78B | |
| +20.44% | 21.89B | |
| +10.94% | 14.45B | |
| +13.07% | 13.63B | |
| +37.46% | 11.49B | |
| -8.59% | 6.85B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +6.35% | 5.06B | |
| -5.36% | 4.66B |
SUN PHARMACEUTICAL INDUSTRIES LTD. 
